Roche, Bayer Present New Evidence Against Abbott

Law360, New York (July 25, 2007, 12:00 AM EDT) -- Roche Diagnostics Operations Inc. and Bayer HealthCare Inc. railed against Abbott Laboratories’ move to keep a key settlement agreement confidential and claimed on Tuesday that they have new evidence to show the deal is crucial to the glucose testing patent case.

Roche and Bayer opposed their rival’s move to quash Bayer’s subpoena of Abbott and LifeScan Inc.’s settlement agreement, in which Abbott allegedly asserted one of the same patents at issue in this action in the U.S. District Court for the Northern District of California....
To view the full article, register now.